Income Statement Balance Sheet Cash Flow Statement
Annual Financials for GenMark Diagnostics Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 998,416 2.5M 5.01M 20.47M 27.4M
Cost of Goods Sold (COGS) incl. D&A 4.33M 4.38M 6.21M 11.64M 15.59M
COGS excluding D&A 2.76M 3.31M 4.88M 10.44M 13.06M
Depreciation & Amortization Expense 1.57M 1.06M 1.33M 1.2M 2.53M
Depreciation 1.4M 995,064 1.23M 998,000 2.19M
Amortization of Intangibles 164,662 68,247 98,000 200,000 342,000
Gross Income (3.33M) (1.87M) (1.2M) 8.83M 11.81M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 17.1M 18.16M 22.67M 30.72M 44.79M
Research & Development 5.63M 6.52M 8.74M 13.54M 22.06M
Other SG&A 11.47M 11.64M 13.93M 17.18M 22.73M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 0 0 1.9M
EBIT after Unusual Expense 0 0 0 0 (1.9M)
Non Operating Income/Expense 303,523 1.64M 19,000 (15,000) 583,000
Non-Operating Interest Income 33,222 - 21,000 0 717,000
Equity in Affiliates (Pretax) - 0 0 - 0
Interest Expense - 582 95,000 49,000 19,000
Gross Interest Expense - 582 95,000 49,000 19,000
Interest Capitalized 0 0 - 0 0
Pretax Income (20.1M) (18.39M) (23.92M) (21.96M) (33.6M)
Income Tax (138,770) 15,324 52,000 148,000 44,000
Income Tax - Current Domestic (162,467) - 20,000 103,000 44,000
Income Tax - Current Foreign 0 - 32,000 45,000 0
Income Tax - Deferred Domestic 23,697 - - - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (19.96M) (18.4M) (23.97M) (22.1M) (33.64M)
Minority Interest Expense 0 0 0 0 0
Net Income (19.96M) (18.4M) (23.97M) (22.1M) (33.64M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (19.96M) (18.4M) (23.97M) (22.1M) (33.64M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (19.96M) (18.4M) (23.97M) (22.1M) (33.64M)
EPS (Basic) (2.81) (1.88) (1.45) (0.84) (0.95)
Basic Shares Outstanding 7.1M 9.8M 16.57M 26.22M 35.25M
EPS (Diluted) (2.81) (1.88) (1.45) (0.84) (0.95)
Diluted Shares Outstanding 7.1M 9.8M 16.57M 26.22M 35.25M
EBITDA (18.87M) (18.97M) (22.54M) (20.69M) (30.45M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.